Metabolic, pathologic, and genetic analysis of prostate tissues: Quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy

NMR in Biomedicine

Volumn 23, Issue 4, 2010, Pages 391-398

  Santos, Carissa F ^a   Kurhanewicz, John ^a   Tabatabai, Z Laura ^a,c   Simko, Jeffry P ^a   Keshari, Kayvan R ^a   Gbegnon, Akpene ^a   DeLos Santos, Romelyn ^a   Federman, Scot ^b   Shinohara, Katsuto ^b   Carroll, Peter R ^b   Haqq, Christopher M ^b,d   Swanson, Mark G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Ortho Biotech Oncology Research and Development   (United States)

Author keywords

cDNA microarray; Gene expression; High resolution magic angle spinning (HR MAS) spectroscopy; Prostate cancer; Radical prostatectomy; RNA integrity number (RIN); Significance analysis of microarrays (SAM); Transrectal ultrasound (TRUS) guided biopsy

Indexed keywords

CDNA MICROARRAYS; HIGH RESOLUTION MAGIC ANGLE SPINNING; PROSTATE CANCERS; RADICAL PROSTATECTOMY; SIGNIFICANCE ANALYSIS OF MICROARRAYS; TRANSRECTAL ULTRASOUND; TRANSRECTAL ULTRASOUND (TRUS) GUIDED BIOPSY;

AMPLIFICATION; BIOPSY; CARBON DIOXIDE; GENE EXPRESSION; HISTOLOGY; MICROARRAYS; QUALITY ASSURANCE; RNA; TISSUE; TRANSPLANTS; ULTRASONICS; UROLOGY;

SPECTRUM ANALYSIS;

COMPLEMENTARY DNA; MESSENGER RNA; RNA;

ARTICLE; BIOPSY; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DNA MICROARRAY; GENE AMPLIFICATION; GENETIC ANALYSIS; HIGH RESOLUTION MAGIC ANGLE SPINNING SPECTROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE; QUANTITATIVE ANALYSIS;

BIOPSY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; RNA STABILITY; RNA, MESSENGER;

EID: 77951573325     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1474     Document Type: Article

References (55)

1. Cheng LL, Anthony DC, Comite AR, Black PM, Tzika AA, Gonzalez RG. Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy. Neuro.-Oncol 2000; 2(2): 87-95.
2. Cheng LL, Wu CL, Smith MR, Gonzalez RG. Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS H-1 NMR spectroscopy at 9.4 T. FEBS Lett. 2001; 494(1-2): 112-116.
3. Swanson MG, Vigneron DB, Tabatabai ZL, Males RG, Schmitt L, Carroll PR, James JK, Hurd RE, Kurhanewicz J. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn. Reson. Med. 2003; 50(5): 944-954.
4. Swanson MG, Zektzer AS, Tabatabai ZL, Simko J, Jarso S, Keshari KR, Schmitt L, Carroll PR, Shinohara K, Vigneron DB, Kurhanewicz J. Quantitative analysis of prostate metabolites using H-1 HR-MAS spectroscopy. Magn. Reson. Med. 2006; 55(6): 1257-1264.
5. Tzika AA, Astrakas L, Cao HH, Mintzopoulos D, Andronesi OC, Mindrinos M, Zhang JW, Rahme LG, Blekas KD, Likas AC, Galatsanos NP, Carroll RS, Black PM. Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies. Int. J. Mol. Med. 2007; 20(2): 199-208.
6. Griffin JL, Blenkiron C, Valonen PK, Caldas C, Kauppinen RA. High-resolution magic angle spinning H-1 NMR spectroscopy and reverse transcription-PCR analysis of apoptosis in a rat glioma. Anal. Chem. 2006; 78(5): 1546-1552.
7. Griffin JL, Bonney SA, Mann C, Hebbachi AM, Gibbons GF, Nicholson JK, Shoulders CC, Scott J. An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver. Physiol. Genomics 2004; 17(2): 140-149. (Pubitemid 38924160)
8. Griffin JL, Shockcor JP. Metabolic profiles of cancer cells. Nat. Rev. Cancer 2004; 4(7): 551-561.
9. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J. Magn. Reson. Imaging 2002; 16(4): 451-463.
10. Costello LC, Franklin RB. 'Why do tumour cells glycolyse?': From glycolysis through citrate to lipogenesis. Mol. Cell. Biochem 2005; 280(1-2): 1-8.
11. Altenberg B, Greulich KO. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 2004; 84(6): 1014-1020. (Pubitemid 39469126)
12. Franklin RB, Feng P, Milon B, Desouki MM, Singh KK, Kajdacsy-Balla A, Bagasra O, Costello LC. hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol. Cancer 2005; 4: 32. (Pubitemid 41461192)
13. Liu X, Wang L, Lin Y, Teng Q, Zhao C, Hu H, Chi W. Ornithine decarboxylase activity and its gene expression are increased in benign hyperplastic prostate. Prostate 2000; 43(2): 83-87. (Pubitemid 30220610)
14. Tessem MG, Swanson MG, Keshari KR, Albers MJ, Joun D, Tabatabai ZL, Simko JP, Shinohara K, Nelson SJ, Vigneron DB, Gribbestad IS, Kurhanewicz J. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magn. Reson. Med. 2008; 60(3): 510-516.
15. Dahiya R, Boyle B, Goldberg BC, Yoon WH, Konety B, Chen K, Yen TS, Blumenfeld W, Narayan P. Metastasis-associated alterations in phospholipids and fatty acids of human prostatic adenocarcinoma cell lines. Biochem. Cell. Biol. 1992; 70(7): 548-554.
16. Swanson MG, Keshari KR, Tabatabai ZL, Simko JP, Shinohara K, Carroll PR, Zektzer AS, Kurhanewicz J. Quantitation of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy. Magn. Reson. Med. 2008; 60(1): 33-40.
17. Narayan P, Dahiya R. Alterations in sphingomyelin and fatty acids in human benign prostatic hyperplasia and prostatic cancer. Biomed. Biochim. Acta. 1991; 50(9): 1099-1108.
18. Ornish D, Magbanua MJM, Weidner G, Weinberg V, Kemp C, Green C, Mattie MD, Marlin R, Simko J, Shinohara K, Haqq CM, Carroll PR. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc. Natl. Acad. Sci. USA. 2008; 105(24): 8369-8374.
19. Stamey TA, Caldwell MC, Fan ZB, Zhang ZM, McNeal JE, Nolley R, Chen ZX, Mahadevappa M, Warrington JA. Genetic profiling of Gleason grade 4/5 prostate cancer: Which is the best prostatic control tissue? J. Urol. 2003; 170(6): 2263-2268. (Pubitemid 37413972)
20. Wu CL, Taylor JL, He WL, Zepeda AG, Halpern EF, Bielecki A, Gonzalez RG, Cheng LL. Proton high-resolution magic angle spinning NMR analysis of fresh and previously frozen tissue of human prostate. Magn. Reson. Med. 2003; 50(6): 1307-1311.
21. Jochumsen KM, Tan QH, Dahlgaard J, Kruse TA, Mogensen O. RNA quality and gene expression analysis of ovarian tumor tissue undergoing repeated thaw-freezing. Exp. Mol. Pathol 2007; 82(1): 95-102.
22. Best S, Sawers Y, Fu VX, Almassi N, Huang W, Jarrard DF. Integrity of prostatic tissue for molecular analysis after robotic-assisted laparoscopic and open prostatectomy. Urology 2007; 70(2): 328-332. (Pubitemid 47362264)
23. Schlomm T, Naekel E, Luebke A, Buness A, Chun FKH, Steuber T, Graefen M, Simon R, Sauter CG, Poustka A, Huland H, Erbersdobler A, Sueltmann H, Hellwinkel OJC. Marked gene transcript level alterations occur early during radical prostatectomy. Eur. Urol. 2008; 53(2): 333-346.
24. Martinez-Granados B, Monleon D, Martinez-Bisbal MC, Rodrigo JM, del Lmo J, Lluch P, Ferrandez A, Marti-Bonmati L, Celda B. Metabolite identification in human liver needle biopsies by high-resolution magic angle spinning H-1 NMR spectroscopy. NMR Biomed 2006; 19(1): 90-100. (Pubitemid 43250794)
25. Burns MA, Taylor JL, Wu CL, Zepeda AG, Bielecki A, Cory D, Cheng LL. Reduction of spinning sidebands in proton NMR of human prostate tissue with slow high-resolution magic angle spinning. Magn. Reson. Med. 2005; 54(1): 34-42.
26. Middleton DA, Bradley DP, Connor SC, Mullins PG, Reid DG. The effect of sample freezing on proton magic-angle spinning NMR spectra of biological tissue. Magn. Reson. Med. 1998; 40(1): 166-169.
27. Taylor JL, Wu CL, Cory D, Gonzalez RG, Bielecki A, Cheng LL. High-resolution magic angle spinning proton NMR analysis of human-prostate tissue with slow spinning rates. Magn. Reson. Med. 2003; 50(3): 627-632.
28. Wind RA, Hu JZ. In vivo and ex vivo high-resolution H-1 NMR in biological systems using low-speed magic angle spinning. Prog. Nucl. Mag. Res. Sp. 2006; 49: 207-259.
29. Payne GS, Troy H, Vaidya SJ, Griffiths JR, Leach MO, Chung YL. Evaluation of P-31 high-resolution magic angle spinning of intact tissue samples. NMR Biomed 2006; 19(5): 593-598. (Pubitemid 44240785)
30. Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, Gribbestad IS. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed 2006; 19(1): 30-40. (Pubitemid 43250787)
31. Tugnoli V, Schenetti L, Mucci A, Parenti F, Cagnoli R, Righi V, Trinchero A, Nocetti L, Toraci C, Mavilla L, Trentini G, Zunarelli E, Tosi MR. Ex vivo HR-MAS MRS of human meningiomas: a comparison with in vivo H-1 MR spectra. Int. J. Mol. Med. 2006; 18(5): 859-869.
32. Sodowich BI, Fadl I, Burns C. Method validation of in vitro RNA transcript analysis on the Agilent 2100 Bioanalyzer. Electrophoresis 2007; 28(14): 2368-2378. (Pubitemid 47162932)
33. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M, Ragg T. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol. 2006; 7: 3.
34. Baugh LR, Hill AA, Brown EL, Hunter CP. Quantitative analysis of mRNA amplification by in vitro transcription. Nucleic. Acids. Res. 2001; 29(5): e29.
35. Derisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen YD, Su YA, Trent JM. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet 1996; 14(4): 457-460. (Pubitemid 26414590)
36. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA. 1998; 95(25): 14863-14868.
37. Saldanha AJ. Java Treeview-extensible visualization of microarray data. Bioinformatics 2004; 20(17): 3246-3248.
38. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA. 2001; 98(9): 5116-5121.
39. Cheng LL, Lean CL, Bogdanova A, Wright SC, Ackerman JL, Brady TJ, Garrido L. Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic-angle spinning. Magn. Reson. Med. 1996; 36(5): 653-658.
40. Beckonert O, Keun HC, Ebbels TMD, Bundy J, Holmes E, Lindon JC, Nicholson JK. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protocols 2007; 2(11): 2692-2703.
41. Scott KM, Fanta P, Calaluce R, Dalkin B, Weinstein RS, Nagle RB. Diagnostic frozen prostate sextant biopsies: An approach for preserving protein and RNA for additional studies. Prostate 2000; 44(4): 296-302.
42. Ohl F, Jung M, Xu CL, Stephan C, Rabien A, Burkhardt M, Nitsche A, Kristiansen G, Loening SA, Radonic A, Jung K. Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization? J. Mol. Med. 2005; 83(12): 1014-1024.
43. Rhodes DR, Sanda MG, Otte AP, Chinnaiyan AM, Rubin MA. Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. J. Natl. Cancer. Inst. 2003; 95(9): 661-668.
44. Luo J, Duggan DJ, Chen YD, Sauvageot J, Ewing CM, Bittner ML, Trent JM, Isaacs WB. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res. 2001; 61(12): 4683-4688. (Pubitemid 32691876)
45. Jhavar S, Corbishley CM, Dearnaley D, Fisher C, Falconer A, Parker C, Eeles R, Cooper CS. Construction of tissue microarrays from prostate needle biopsy specimens. Br. J. Cancer 2005; 93(4): 478-482. (Pubitemid 43080024)
46. Singh SS, Mehedint DC, Ford OH, Maygarden SJ, Ruiz B, Mohler JL. Feasibility of constructing tissue microarrays from diagnostic prostate biopsies. Prostate 2007; 67(10): 1011-1018. (Pubitemid 46983331)
47. Lin DW, Coleman IM, Hawley S, Dumpit R, Gifford D, Kezele P, Hung H, Knudsen BS, Kristal AR, Nelson PS. Influence of surgical manipulation on prostate gene expression: Implications for molecular correlates of treatment effects and disease prognosis. J. Clin. Oncol 2006; 24(23): 3763-3770. (Pubitemid 46622315)
48. Dash A, Maine IP, Varambally S, Shen R, Chinnaiyan AM, Rubin MA. Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens. Am. J. Pathol 2002; 161(5): 1743-1748. (Pubitemid 35265532)
49. Schoor O, Weinschenk T, Hennenlotter J, Corvin S, Stenzl A, Rammensee HG, Stevanovic S. Moderate degradation does not preclude microarray analysis of small amounts of RNA. Biotechniques 2003; 35(6): 1192-1201. (Pubitemid 37517496)
50. Strand C, Enell J, Hedenfalk I, Ferno M. RNA quality in frozen breast cancer samples and the influence on gene expression analysis - a comparison of three evaluation methods using microcapillary electrophoresis traces. BMC Mol. Biol. 2007; 8: 38.
51. Ohashi Y, Creek KE, Pirisi L, Kalus R, Young SR. RNA degradation in human breast tissue after surgical removal: a time-course study. Exp. Mol. Pathol 2004; 77(2): 98-103.
52. Almeida A, Thiery JP, Magdelenat H, Radvanyi F. Gene expression analysis by real-time reverse transcription polymerase chain reaction: influence of tissue handling. Anal. Biochem 2004; 328(2): 101-108. (Pubitemid 38542924)
53. Copois V, Bibeau F, Bascoul-Mollevi C, Salvetat N, Chalbos P, Bareil C, Candeil L, Fraslon C, Conseiller E, Granci V, Maziere P, Kramar A, Ychou M, Pau B, Martineau P, Molina F, Del Rio M. Impact of RNA degradation on gene expression profiles: Assessment of different methods to reliably determine RNA quality. J. Biotechnol 2007; 127(4): 549-559. (Pubitemid 44959110)
54. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000; 25(2): 169-193.
55. Schrader AJ, Lauber J, Lechner O, Heidenreich A, Hofmann R, Buer J. Application of real-time reverse transcriptase-polymerase chain reaction in urological oncology. J. Urol. 2003; 169(5): 1858-1864. (Pubitemid 36443534)